Food and Drug Administration Office of Criminal Investigations The Hematology and Oncology Center of Iowa, P.C., located in Clive, Iowa, and its only corporate officer, Dr. Magdy Elsawy, have agreed to pay $176,460 to settle allegations that they violated the False Claims Act by submitting false billings for cancer drugs that were…
October 26, 2017: Founder and Owner of Pharmaceutical Company Insys Arrested and Charged with Racketeering
Food and Drug Administration Office of Criminal Investigations Defendant and other executives allegedly bribed doctors and pharmacists to prescribe fentanyl spray meant for breakthrough cancer pain BOSTON – The founder and majority owner of Insys Therapeutics Inc., was arrested today and charged with leading a nationwide conspiracy to profit by using bribes and…
September 25, 2017: Pharmacy Manager Pleads Guilty to Illegal Prescription Drug Diversion and Money Laundering
Food and Drug Administration Office of Criminal Investigations A pharmacy manager from Burnsville, North Carolina, pleaded guilty for her role in the fraudulent diversion of prescription drugs and money laundering, the Department of Justice announced today. Karen Ann Turner, 37, pleaded guilty in the Western District of North Carolina to one count of…
November 3, 2017: Five Charged in Alleged Opioid Prescription, Healthcare Fraud Scheme
Food and Drug Administration Office of Criminal Investigations PROVIDENCE – Five individuals have been charged by way of federal criminal complaints filed in U.S. District Court in Providence for their alleged participation in a conspiracy to create fraudulent prescriptions for opioid pills and, at times, unlawfully pay for the prescriptions with the use…
November 28, 2017: Champaign, Illinois, Resident Guilty of Producing and Selling Over 80,000 Homemade Tramadol Capsules to Customers Without Verifying Prescriptions
Food and Drug Administration Office of Criminal Investigations OWENSBORO, Ky. – A Champaign, Illinois, resident pleaded guilty in United States District Court today, before Chief Judge Joseph H. McKinley, to four felony charges including distributing Tramadol, a Schedule IV controlled substance, introduction of misbranded drugs, and wire fraud, announced United States Attorney Russell…
September 19, 2018: Springfield Doctor Sentenced for Illegally Sharing Patient Medical Files
Food and Drug Administration Office of Criminal Investigations BOSTON – A Springfield gynecologist was sentenced today in connection with allowing a pharmaceutical sales representative to access patient records and lying to federal investigators. Rita Luthra, M.D., 67, of Longmeadow, was sentenced by U.S. District Court Judge Mark G. Mastroianni to one year of…
October 12, 2016: Colombian National Charged for Unlawfully Injecting Silicone into Victims Bodies
Food and Drug Administration Office of Criminal Investigations A Colombian national pled guilty to unlawfully injecting silicone into victim’s bodies for aesthetic enhancements, without a medical license or approval by the U.S. Food and Drug Administration. Wifredo A. Ferrer, United States Attorney for the Southern District of Florida, and Justin Green, Special…
September 20, 2017: Miami-Dade Resident Sentenced to More Than 4 Years in Prison for Managing a Miami Spa Performing Illicit Silicone Injections
Food and Drug Administration Office of Criminal Investigations Benjamin G. Greenberg, United States Attorney for the Southern District of Florida; Justin D. Green, Special Agent in Charge, U.S. Food and Drug Administration, Office of Criminal Investigations (FDA-OCI), Miami Field Office; Mark Selby, Special Agent in Charge, U.S. Immigration and Customs Enforcement’s Homeland Security…
September 8, 2017: Galena Biopharma Inc. to Pay More than $7.55 Million to Resolve Alleged False Claims Related to Opioid Drug
Food and Drug Administration Office of Criminal Investigations Galena Biopharma Inc. (Galena) will pay more than $7.55 million to resolve allegations under the civil False Claims Act that it paid kickbacks to doctors to induce them to prescribe its fentanyl-based drug Abstral, the Department of Justice announced today. “Given the dangers associated with…
September 6, 2017: Bronx Pharmacist Pleads Guilty To Illegally Selling Millions Of Prescription Pills On The Internet And Agrees To Forfeit $9 Million
Food and Drug Administration Office of Criminal Investigations Joon H. Kim, the Acting United States Attorney for the Southern District of New York, and Carl J. Kotowski, the Special Agent-in-Charge of the New Jersey Division of the Drug Enforcement Administration (“DEA”), announced that MAURICE MALIN pled guilty today before U.S. Magistrate Judge Andrew…